Network Marketing News: Oxygen4Energy Joins the Multi-Level Marketing Industry with its Portable Canned Oxygen

95% pure portable oxygen from Oxygen4Energy is destined to be the next big health supplement product.

2010-12-13

LAKE FOREST, CA, December 13, 2010 (Press-News.org) Oxygen4energy markets convenient portable canisters containing 95% oxygen enriched air. There are no stimulants, artificial ingredients, sugars or calories, just concentrated gaseous oxygen (O2) that enters the bloodstream in seconds after it is inhaled through the mouth or nose. The product is similar to what pro football players use on the sidelines except in portable canisters that allow a user to flood their body with supplemental oxygen at any given time.

The main target market for the product is sports and fitness because it is very beneficial for physical performance. However, supplemental oxygen can also be beneficial for hangovers, seniors, stress relief, brain function, general energy and vitality, and high altitude acclimation.

After 2 years of selling oxygen products strictly through e-commerce, Oxygen4Energy founder Craig Inaba decided to merge with the premiere canned oxygen manufacturer in the U.S., owned and operated by Jeffrey L. Perlmutter, the person responsible for pioneering the sport of paintball and creating a $500 million industry. The two men had worked well together for two years and both agreed that joining forces under a new Network Marketing platform was the most effective way to get the product out to a broad demographic of consumers.

Oxygen4Energy clearly states that the product is for recreational use only and is not intended to treat, cure or prevent any medical disease. They also clearly state that the product does not contain medical grade oxygen and anyone with existing medical conditions should not take the product without first consulting a medical doctor.

For more information, go to: www.Oxygen4energy.com.

ELSE PRESS RELEASES FROM THIS DATE:

EFW2 2011- W2 Software from W2Mate.com Supports 2010 W2 Forms Efile Including HIRE Act Exempt Wages and Tips; W2 Mate Makes Electronic W2 Filing Affordable and Stress FREE

2010-12-13

Real Business Solutions (www.RealTaxTools.com), a leading W2 software vendor, announced today the release of the W2 Electronic Reporting option for the 2010/2011 tax season. Through W2 Mate, the W2 Preparation Software offered by the company, business filers and accounting firms can E-File unlimited number of W2s with the Social Security Administration. Businesses looking for HIRE Act reporting compliance can benefit from the updated support for the 2010 EFW2 format. A FREE W2 Software trial can be downloaded from the company's website by visiting http://www.W2Mate.com. "W2 ...

Higher co-payments increase chance of early discontinuation, inadequate use of breast cancer therapy

2010-12-12

SAN ANTONIO — A higher prescription co-payment, especially among older women, is associated with both early discontinuation and incomplete use of adjuvant aromatase inhibitor therapy, a life-saving therapy for women with hormone sensitive early-stage breast cancer. Dawn L. Hershman, M.D., M.S., associate professor of medicine and epidemiology and co-director of the Breast Cancer Program at the Herbert Irving Comprehensive Cancer Center at Columbia University, presented detailed study results at the 33rd CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12, ...

Unique needs and outcomes of pregnant women with breast cancer identified

2010-12-12

SAN ANTONIO — Do not delay treatment of breast cancer just because a woman is pregnant, said lead researcher Sibylle Loibl, Dr. med, of the German Breast Group. This suggestion is based on study results detailing the effects of different treatment options on the infant. Loibl presented this data at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 8-12, 2010. "At the time we started the study in 2003, there was hardly any information on breast cancer therapy during pregnancy, but we felt there was a medical need for it," she said. Although ...

Novel imaging technique may reduce lymphedema in breast cancer patients

2010-12-12

SAN ANTONIO -- With guidance from a specialized scan, radiation oncologists at Mayo Clinic (http://www.mayoclinic.org/) were able to reduce by 55 percent the number of lymph nodes critical for removing fluid from the arm that received damaging radiation doses. VIDEO ALERT: Additional audio and video resources, including excerpts from an interview with Dr. Andrea Cheville and other researchers presenting at San Antonio Breast Cancer Symposium, are available on the Mayo Clinic News Blog (http://newsblog.mayoclinic.org/2010/12/06/lymphedema-study/). These materials also ...

Expert analysis of HER2 tests reveals issues with reliability, Mayo Clinic researchers say

2010-12-12

SAN ANTONIO -- Results for testing breast tumors for HER2 (http://www.mayoclinic.com/health/breast-cancer/AN00495) proteins and genes is most often straightforward when one piece of tumor (a single tumor block) is analyzed. However, tumors can be diverse, and researchers at Mayo Clinic (http://www.mayoclinic.org/) found that HER2 results can vary in up to 10 percent of patients when several tumor blocks are analyzed. This could have significant implications for patient treatment, say the researchers, who are presenting their findings at the 33rd Annual CTRC-AACR San ...

Higher co-payments increase chance of early discontinuation of breast cancer therapy

2010-12-12

A higher prescription co-payment, especially among older women, is associated with both early discontinuation and incomplete use of adjuvant aromatase inhibitor therapy, a life-saving therapy for women with hormone sensitive early stage breast cancer. Dawn L. Hershman, MD, associate professor of medicine and epidemiology and co-director of the Breast Cancer Program at the Herbert Irving Comprehensive Cancer Center at Columbia University, will be presenting detailed study results at The 33rd CTRC-AACR San Antonio Breast Cancer Symposium, a comprehensive scientific meeting ...

Depression drug may relieve pain from breast cancer treatment, U-M study finds

2010-12-12

ANN ARBOR, Mich. — A drug commonly used to treat depression and anxiety disorder was effective at reducing joint and muscle pain associated with a breast cancer treatment, according to a study from the University of Michigan Comprehensive Cancer Center. The women in the study were taking aromatase inhibitors, a type of drug designed to block the production of estrogen, which fuels some breast cancers. About half of women taking these drugs experience aches and pains in their joints and muscles that cannot be adequately relieved by over-the-counter painkillers. Up to 20 ...

Ubiquitous sugar molecule could be key to repairing deep wound without scarring

2010-12-12

Blocking fragments of the sugar molecule hyaluronan that triggers inflammation could be the key to robust healing and less scarring in deep wounds, Canadian researchers reported at the American Society for Cell Biology's 50th Annual Meeting in Philadelphia. In laboratory rats, the small peptide, named 15-1, which blocks fragments of the ubiquitous sugar molecule, hyaluronan, promoted wound healing, minimized scarring and forged stronger new tissue. These effects did not occur in the untreated animals in the study, according to Cornelia Tölg, Ph.D., of the London (Ontario) ...

Pomegranate juice components inhibit cancer cell migration; in vivo testing planned

2010-12-12

Researchers at the University of California, Riverside (UCR), have identified components in pomegranate juice that seem to inhibit the movement of cancer cells and weaken their attraction to a chemical signal that has been shown to promote the metastasis of prostate cancer to the bone, according to a presentation today at the American Society for Cell Biology's 50th Annual Meeting in Philadelphia. The researchers in the UCR laboratory of Manuela Martins-Green, Ph.D., plan additional testing in an in vivo model for prostate cancer to determine dose-dependent effects and ...

Human spermatogonial stem cells become insulin-secreting pancreatic cells in lab

2010-12-12

Insulin-secreting pancreatic islet cells have been generated from human spermatogonial stem cells (SSCs) directly isolated from human testicular tissue, researchers reported today at the American Association of Cell Biology 50th Annual Meeting in Philadelphia. When grafted into diabetic mice that lacked a transplant-rejecting immune system, the bioengineered cells functioned much like somatic β-islet cells, the Georgetown University (GU) Medical Center researchers said. By decreasing the animals' blood glucose levels, the human-derived islet cells demonstrated ...

Network Marketing News: Oxygen4Energy Joins the Multi-Level Marketing Industry with its Portable Canned Oxygen

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: